MDxHealth SA banner
M

MDxHealth SA
LSE:0O8G

Watchlist Manager
MDxHealth SA
LSE:0O8G
Watchlist
Price: 3.89 EUR 3.6% Market Closed
Market Cap: €168.5k

Wall St Price Targets

0O8G Price Targets Summary
MDxHealth SA

Wall Street analysts forecast 0O8G stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0O8G is 12.19 EUR with a low forecast of 9.79 EUR and a high forecast of 15.26 EUR.

Lowest Forecast
Price Target
9.79 EUR
152% Upside
Average Forecast
Price Target
12.19 EUR
213% Upside
Highest Forecast
Price Target
15.26 EUR
292% Upside
MDxHealth SA Competitors:
Price Targets
VRNS
Varonis Systems Inc
15% Upside
NWSA
News Corp
37% Upside
TENB
Tenable Holdings Inc
8% Upside
DXPE
DXP Enterprises Inc
1% Upside

Revenue
Forecast

27% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
27% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 27%. The projected CAGR for the next 4 years is 22%.

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-39%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-39%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 0O8G's stock price target?
Price Target
12.19 EUR

According to Wall Street analysts, the average 1-year price target for 0O8G is 12.19 EUR with a low forecast of 9.79 EUR and a high forecast of 15.26 EUR.

What is the Revenue forecast for MDxHealth SA?
Projected CAGR
22%

Over the last 14 years, the compound annual growth rate for Revenue has been 27%. The projected CAGR for the next 4 years is 22%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett